Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Coca-Cola Consolidated
COKE
$13.2B
| $1.61M | ﹤0.01% |
25,390
+7,560
| +42% | +$468K |
|
3602
Citi Trends
CTRN
$560M
| $1.61M | ﹤0.01% |
91,362
+43,562
| +91% | +$751K |
|
3603
American Superconductor
AMSC
$1.38B
| $1.61M | ﹤0.01% |
257,171
+216,712
| +536% | +$1.06M |
|
3604
PUT
Vera Therapeutics
VERA
$2.46B
| $1.6M | ﹤0.01% |
+100,000
| New | +$903K |
|
3605
Keros Therapeutics
KROS
$219M
| $1.6M | ﹤0.01% |
39,896
+15,523
| +64% | +$680K |
|
3606
CALL
Elastic
ESTC
$10.5B
| $1.6M | ﹤0.01% |
+25,000
| New | +$1.57M |
|
|
DHC
3607
Diversified Healthcare Trust
DHC
$1.85B
| $1.6M | ﹤0.01% |
711,794
-1,290,313
| -64% | -$1.85M |
|
3608
PUT
State Street Communication Services Select Sector SPDR ETF
XLC
$22.8B
| $1.6M | ﹤0.01% |
24,600
+6,400
| +35% | +$390K |
|
3609
iShares MBS ETF
MBB
$39B
| $1.6M | ﹤0.01% |
17,160
-3,909
| -19% | -$368K |
|
3610
Global X Silver Miners ETF NEW
SIL
$5.38B
| $1.6M | ﹤0.01% |
61,558
-242,536
| -80% | -$6.98M |
|
3611
Deutsche Bank
DB
$75.8B
| $1.6M | ﹤0.01% |
151,928
+73,829
| +95% | +$778K |
|
3612
CALL
iShares MSCI South Korea ETF
EWY
$28B
| $1.6M | ﹤0.01% |
25,200
+4,500
| +22% | +$282K |
|
3613
CALL
Jacobs Solutions
J
$17.8B
| $1.59M | ﹤0.01% |
16,200
| – | – |
|
|
ARCE
3614
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $1.59M | ﹤0.01% |
131,104
+74,762
| +133% | +$886K |
|
3615
Esquire Financial Holdings
ESQ
$1.36B
| $1.59M | ﹤0.01% |
34,743
-30,901
| -47% | -$1.27M |
|
3616
Adeia
ADEA
$2.84B
| $1.58M | ﹤0.01% |
143,927
-283,088
| -66% | -$2.58M |
|
|
GAP
3617
CALL
The Gap Inc
GAP
$8.45B
| $1.58M | ﹤0.01% |
177,200
-138,500
| -44% | -$1.24M |
|
3618
1stdibs.com
DIBS
$150M
| $1.58M | ﹤0.01% |
423,091
+391,424
| +1,236% | +$1.49M |
|
3619
CALL
Alcoa
AA
$13.3B
| $1.58M | ﹤0.01% |
46,600
+36,500
| +361% | +$1.33M |
|
3620
PUT
MGIC Investment
MTG
$6.36B
| $1.58M | ﹤0.01% |
+100,000
| New | +$1.48M |
|
|
TCOA
3621
DELISTED
Zalatoris Acquisition Corp.
TCOA
| $1.57M | ﹤0.01% |
152,335
| – | – |
|
3622
SkinHealth Systems
SKIN
$89.1M
| $1.57M | ﹤0.01% |
187,948
+60,586
| +48% | +$630K |
|
3623
CALL
Trade Desk
TTD
$6.38B
| $1.57M | ﹤0.01% |
+20,300
| New | +$1.37M |
|
|
VXRT
3624
DELISTED
Vaxart
VXRT
| $1.56M | ﹤0.01% |
2,143,638
+2,067,766
| +2,725% | +$1.92M |
|
|
FUSN
3625
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $1.56M | ﹤0.01% |
334,577
-69,211
| -17% | -$299K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.